Evidence map›Paper›PMID 38932019›Full record

ReviewPolymers2024

The

Kyle J Stanforth, Maria I Zakhour, Peter I Chater, Matthew D Wilcox, Beth Adamson, Niamh A Robson, Jeffrey P Pearson

Abstract readReview
In one paragraph

Review in Polymers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Intestinal Epithelial-Protective Effects ofJournal of microbiology and biotechnology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Journal of virology · 2025
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kyle J StanforthAelius Biotech, The Medical School, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK.
Maria I ZakhourBiosciences Institute, Newcastle University Biosciences Institute, Catherine Cookson Building, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK.ORCID 0009-0005-4617-3235
Peter I ChaterAelius Biotech, The Medical School, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK.ORCID 0000-0001-8679-0004
Matthew D WilcoxAelius Biotech, The Medical School, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK.
Beth AdamsonAelius Biotech, The Medical School, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK.
Niamh A RobsonAelius Biotech, The Medical School, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK.
Jeffrey P PearsonBiosciences Institute, Newcastle University Biosciences Institute, Catherine Cookson Building, Framlington Place, Newcastle-upon-Tyne NE2 4HH, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MUC2 mucin, the primary gel-forming component of intestinal mucus, is well researched and a model of polymerisation and post-secretory organisation has been published previously. Recently, several significant developments have been made which either introduce new ideas or challenge previous theories. New ideas include an overhaul of the MUC2 C-terminal globular structure which is proposed to harbour several previously unobserved domains, and include a site for an extra intermolecular disulphide bridge dimer between the cysteine 4379 of adjacent MUC2 C-termini. MUC2 polymers are also now thought to be secreted attached to the epithelial surface of goblet cells in the small intestine and removed following secretion via a metalloprotease meprin β-mediated cleavage of the von Willebrand D2 domain of the N-terminus. It remains unclear whether MUC2 forms intermolecular dimers, trimers, or both, at the N-termini during polymerisation, with several articles supporting either trimer or dimer formation. The presence of a firm inner mucus layer in the small intestine is similarly unclear. Considering this recent research, this review proposes an update to the previous model of MUC2 polymerisation and secretion, considers conflicting theories and data, and highlights the importance of this research to the understanding of MUC2 mucus layers in health and disease.

Indexed as

cystic fibrosisgastrointestinal tractMUC2mucinsmucus barrierpolymerization

Identifiers

PMID38932019
PMCPMC11207715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.